Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Frequently asked questions
What sector does Nordic Nanovector ASA (8NN) operate in?
Nordic Nanovector ASA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Nordic Nanovector ASA (8NN) current stock price?
As of the latest data, Nordic Nanovector ASA stock price is €0.49, with a previous close of €0.47. Nordic Nanovector ASA gained €0.01 in the last trading session, representing a 2.64% increase.
What is Nordic Nanovector ASA (8NN) current market capitalization?
Nordic Nanovector ASA market cap is approximately 175.14 million.
What is Nordic Nanovector ASA (8NN) Earnings Per Share (EPS)?
The trailing EPS is -€0.02.
Does Nordic Nanovector ASA (8NN) pay dividends?
No. Nordic Nanovector ASA does not pay a dividend.
When is Nordic Nanovector ASA (8NN) next earnings report?
Nordic Nanovector ASA is expected to release its next earnings report on June 30, 2026.
What is Nordic Nanovector ASA (8NN) beta (volatility) score?
Nordic Nanovector ASA has a beta of -0.273, indicating lower volatility than the overall market.